NutraCast: Greg Leyer, PhD, on probiotics for vulnerable populations

This content item was originally published on www.nutraingredients-usa.com, a William Reed online publication.

By Danielle Masterson contact

- Last updated on GMT

NutraCast: Greg Leyer, PhD, on probiotics for vulnerable populations

Related tags: nutracast, Probiotic, Infant nutrition

The number of preemies receiving probiotics in the US and Canada is increasing steadily, but skeptics say there is potential for harm in this vulnerable population. Greg Leyer, PhD, the Senior Director of Scientific Affairs, at Chr. Hansen says if done correctly, dietary supplements—including probiotics—can be used safely in these vulnerable populations.

The American Academy of Pediatrics (AAP) recently published a report​ where they examined the evidence for probiotics to prevent morbidity and mortality in preterm infants. They concluded that probiotics could not be recommended. 

The report landed on the conclusion that “clinicians must be aware of the lack of regulatory standards for commercially available probiotic preparations manufactured as dietary supplements and the potential for contamination with pathogenic species.”

So are probiotics regulated? “Yep” ​Leyer said. “It’s all about the intended use and traditionally, probiotics have been sold predominantly in foods and as a dietary supplement. So more in the food space, whereby, it's very limited in terms of what we can say about probiotics in terms of health benefits. You can't treat, cure, mitigate diseases for example, on a product label, although they might be studied in those areas. So, the concept of probiotics, that they’re not being regulated is false, probiotics are regulated as a dietary supplement ingredient would be regulated. There is certain federal standards that we need to meet as a manufacturer. There's federal guidelines that are specific to dietary supplements in terms of how they are manufactured called good manufacturing practices (GMP), which are slightly different from food and slightly different from pharmaceuticals, but they certainly are regulated.”

When it comes to products aimed at infants and preterm infants, Leyer said Chr. Hansen’s approach is a very layered and rigorous process.

“We have our traditional dietary supplement category, which if you walk through any of our facilities, you would be extremely impressed with the cleanliness and the care that we take in it, but then we go a step further for infants,” said Leyer. “We make sure that there's no incompatibility with the ingredients, we make sure that the methods that we’re using for testing all along the value chain from raw ingredient in the fermenter to the probiotic itself, to everything it’s  blended with and packaged into, that the method that we’re using have been validated to practically pharmaceutical standards.”

To hear more about why probiotics are more closely aligned with food rather than pharma, or how hospitals could go about implementing probiotics for vulnerable populations, listen to the NutraCast.

You can also subscribe on iTunes​, Spotify ​, Stitcher​, Google Podcasts​ or wherever you get your podcasts. 

NutraCast is a podcast that focuses on insights from inside the nutrition industry. It is a production by NutraIngredients-USA. Music by Kevin Macleod.

Related news

Show more

Related products

show more

Actilight® and infant nutrition: new perspectives

Actilight® and infant nutrition: new perspectives

Tereos | 31-Aug-2021 | Technical / White Paper

Addition of prebiotic ingredients to formulas started around 30 years ago and is widely recognized by experts. Actilight® scFOS is safe for use in infant...

Your probiotic solutions provider to support Natural Defenses

Your probiotic solutions provider to support Natural Defenses

Lallemand Health Solutions. Quality Probiotics. Complete Solutions. | 23-Jun-2021 | Product Brochure

Lallemand Health Solutions is a vertically integrated probiotic manufacturer specialized in the research, development, and manufacturing of market-ready...

Business case: private label iron supplements

Business case: private label iron supplements

PharmaLinea Ltd. | 18-May-2021 | Case Study

A line of clinically supported private label iron supplements by PharmaLinea is selling nearly 500.000 units/year in a market of under 20 million people.

Related suppliers

Follow us

Products

View more

Webinars